Published in J Med Chem on July 10, 1992
The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J Clin Invest (2001) 1.18
Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon. Br J Pharmacol (1994) 0.96
Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum. Br J Pharmacol (1995) 0.88
The possible role of ATP and PACAP as mediators of apaminsensitive NANC inhibitory junction potentials in circular muscle of guinea-pig colon. Br J Pharmacol (1996) 0.86
Tachykinin NK1 and NK2 receptor antagonists and atropine-resistant ascending excitatory reflex to the circular muscle of the guinea-pig ileum. Br J Pharmacol (1994) 0.83
Correolide, a nor-triterpenoid blocker of Shaker-type Kv1 channels elicits twitches in guinea-pig ileum by stimulating the enteric nervous system and enhancing neurotransmitter release. Br J Pharmacol (2000) 0.82
Shaker-type Kv1 channel blockers increase the peristaltic activity of guinea-pig ileum by stimulating acetylcholine and tachykinins release by the enteric nervous system. Br J Pharmacol (2003) 0.78
Evidence that tachykinin NK2 receptors modulate resting tone in the rat isolated small intestine. Br J Pharmacol (1996) 0.76
Patient participation in decision-making. Soc Sci Med (1998) 8.05
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet (2000) 5.03
Assessment of the completeness and accuracy of computer medical records in four practices committed to recording data on computer. Br J Gen Pract (1995) 5.03
Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J (2001) 4.93
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA (1999) 4.71
Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA (2001) 4.38
Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med (1999) 3.98
Characterization of Mycobacterium tuberculosis strains from Vietnamese patients by Southern blot hybridization. J Clin Microbiol (1993) 3.98
Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR. J Clin Microbiol (1999) 3.96
Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet (1999) 3.61
Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother (2003) 3.24
Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2). Diabet Med (2005) 3.21
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med (1993) 3.18
Identification of human mononuclear leucocyte populations by esterase staining. Clin Exp Immunol (1977) 3.12
Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A (1992) 2.84
Management of traumatic intracranial haematoma. Br Med J (Clin Res Ed) (1982) 2.79
Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc (2001) 2.67
Automated high resolution optical mapping using arrayed, fluid-fixed DNA molecules. Proc Natl Acad Sci U S A (1998) 2.50
Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure. Proc Natl Acad Sci U S A (1986) 2.48
A simple PCR method for rapid genotype analysis of Mycobacterium ulcerans. J Clin Microbiol (2000) 2.43
Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol (1983) 2.42
Ribotyping of Helicobacter pylori from clinical specimens. J Clin Microbiol (1992) 2.35
Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature (1987) 2.31
Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J Virol (1995) 2.23
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1996) 2.12
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. Blood (2000) 2.11
Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus. Microbiology (1994) 1.96
Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol (1988) 1.96
Spatial and temporal operation of the Scotia Sea ecosystem: a review of large-scale links in a krill centred food web. Philos Trans R Soc Lond B Biol Sci (2007) 1.95
The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol (1982) 1.88
Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345. Br J Pharmacol (1991) 1.86
Use of a repetitive element isolated from Mycobacterium tuberculosis in hybridization studies with Mycobacterium bovis: a new tool for epidemiological studies of bovine tuberculosis. Vet Microbiol (1993) 1.85
Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve. Br J Pharmacol (1987) 1.77
Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children. Paediatr Drugs (2001) 1.74
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet (1995) 1.69
Atypical campylobacters associated with gastroenteritis. J Clin Microbiol (1987) 1.62
In vitro replication of adeno-associated virus DNA. Proc Natl Acad Sci U S A (1992) 1.60
Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis (1992) 1.58
Marital discord and childhood behavior problems. J Abnorm Child Psychol (1980) 1.54
The use of the laryngeal mask airway in primary anaesthesia. Anaesthesia (1990) 1.48
Testing for urinary tract colonization before high-dose corticosteroid treatment in acute multiple sclerosis relapses: prospective algorithm validation. Eur J Neurol (2012) 1.47
Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles. J Virol (1990) 1.44
Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein. J Virol (2000) 1.43
Oral oseltamivir in human experimental influenza B infection. Antivir Ther (2000) 1.39
Retracted High rate of human papillomavirus type 16 infection in cytologically normal cervices. Lancet (1989) 1.38
Accuracy of a computer-based anaesthetic audit system. Anaesthesia (1993) 1.38
Adenosine A1 receptor agonist GR79236 suppresses apnea during all sleep stages in the rat. Sleep (1997) 1.38
The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers. J Clin Pharmacol (2000) 1.38
Effect of Soil-Moisture Content on the Rate of Photosynthesis and Respiration in Ladino Clover (Trifolium Repens L.). Plant Physiol (1955) 1.38
Identification of an insertion sequence-like element in a subspecies of Mycobacterium kansasii. J Clin Microbiol (1993) 1.36
Generation and characterization of a defined mutant of Streptococcus suis lacking suilysin. Infect Immun (2001) 1.34
Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea. Br J Pharmacol (1991) 1.33
HIV/AIDS risk in heterosexual college students. A review of a decade of literature. J Am Coll Health (1997) 1.32
Release of acetylcholine and 14 C-glycine from the cat spinal cord in vivo. Br J Pharmacol (1971) 1.30
Comparative analysis of the exopolysaccharide biosynthesis gene clusters from four strains of Lactobacillus rhamnosus. Microbiology (2005) 1.29
Noise exposure of motorcyclists. Ann Occup Hyg (1989) 1.27
The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues. Br J Pharmacol (1990) 1.27
Muscle fibre type changes in hypothyroid myopathy. J Clin Pathol (1975) 1.26
Beta-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters. J Cancer Res Clin Oncol (2000) 1.25
Care management and mental health. BMJ (1993) 1.25
Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin function. Neuropeptides (1991) 1.24
Candida albicans: a review of its history, taxonomy, epidemiology, virulence attributes, and methods of strain differentiation. Int J Oral Maxillofac Surg (1996) 1.23
Identification of Mycobacterium kansasii by DNA hybridization. J Clin Microbiol (1991) 1.22
Isolation of a fastidious Mycobacterium species from two AIDS patients. J Clin Microbiol (1992) 1.21
Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo. J Biol Chem (1992) 1.19
Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques. Am J Pathol (1991) 1.19
A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry (2009) 1.19
Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion. Br J Pharmacol (1987) 1.18
Effect of rapid and conventional cooling methods on the quality of cooked ham joints. Meat Sci (2000) 1.18
Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives. J Antibiot (Tokyo) (1977) 1.17
Multiple sclerosis: diagnosis and the management of acute relapses. Postgrad Med J (2005) 1.17
Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences. J Virol (2001) 1.16
Oesophageal reflux after abdominal vagotomy. Lancet (1965) 1.15
Location of the retinoblastoma susceptibility gene(s) and the human esterase D locus. J Med Genet (1984) 1.15
Temperature modulation of alpha- and beta-adrenoceptors in the isolated frog heart. Br J Pharmacol (1970) 1.15
Human papillomavirus subtype 16a. Lancet (1989) 1.13
Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M. Biochemistry (1992) 1.13
Potent and highly selective neurokinin antagonists. J Med Chem (1990) 1.13
Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist. Br J Pharmacol (1992) 1.12
Misoprostol for induction of labour at term: a more effective agent than dinoprostone vaginal gel. Br J Obstet Gynaecol (1999) 1.11
Characterization and comparison of Australian human spotted fever group rickettsiae. J Clin Microbiol (1992) 1.11
Molecular cloning of cDNA from hepatitis A virus strain HM-175 after multiple passages in vivo and in vitro. J Gen Virol (1986) 1.11
Comparative characterization of rep proteins from the helper-dependent adeno-associated virus type 2 and the autonomous goose parvovirus. J Virol (1999) 1.11
Hypothyroid myopathy. A clinical and pathologaical study. J Pathol (1980) 1.11
Reporting of communicable diseases by university physicians. Public Health Rep (1991) 1.10
Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.09
Percutaneous cytodiagnosis of abdominal masses by ultrasound guided fine needle aspiration biopsy. Acta Radiol Diagn (Stockh) (1981) 1.09
Amino-terminal domain exchange redirects origin-specific interactions of adeno-associated virus rep78 in vitro. J Virol (2001) 1.09
Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain. Eur J Pharmacol (1987) 1.09